Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Creative Biolabs Introduces Full-Process Solutions to Fast-Track Antibody and Biologics Development

The industry is increasingly focused on speeding up antibody validation and biopharmaceutical research and development. Efficient execution of these processes, along with effective management of regulatory milestones, has become a central concern across the field. Creative Biolabs has recently officially launched a full-process service portfolio covering "from discovery to production", providing biopharmaceutical companies with faster, more stable, and more scalable technical channels.

NPIP Webinar Series

Revolutionising Imaging: The Power and Promise of LAFOV PET and the NPIP Network

Webinar 1 | Introduction to Long Axial Field of View (LAFOV) PET: Capabilities and Transformational Potential

(12/01/26 4pm GMT)

Speakers:

Dr Simon R. Cherry, University of California, Davis, and King’s College London
Dr Antonis Kalemis, Siemens Healthineers
Stewart Young, United Imaging

Research Scientist

The United Kingdom Health Security Agency (UKHSA) is a system leader for health security; taking action internationally to strengthen global health security, providing trusted advice to government and the public and reducing inequalities in the way different communities experience and are impacted by infectious disease, environmental hazards, and other threats to health.

AI unlocks Unparalleled Efficiency Gains in Flare™ V11, Cresset’s Leading Software Solution for Digital Molecular Discovery

10 December 2025 - Cambridge, UK; Cresset, a leading provider of digital molecular discovery solutions that combine cutting-edge science with AI/ML, announces the latest release of their flagship CADD platform, Flare. New AI features are complemented by significant advances in existing capabilities such as Flare FEP (Free Energy Perturbation).

Digital Marketing Executive

Join an innovative team as a Digital Marketing Executive, driving multi-channel marketing campaigns and supporting business growth in a dynamic research and technology environment.

Key Responsibilities:
- Develop, implement, and optimise digital marketing campaigns across PPC, SEO, email, and social media platforms.
- Analyse campaign performance using analytics tools, providing actionable insights to improve ROI.
- Create engaging content for websites, blogs, and social media to enhance brand presence.

Multi-omics Analysis Specialist VUGENE Enters Pharmaceutical Services Market with Inotiv collaboration

Vilnius - December 11, 2025 – VUGENE, LLC an intelligent bioinformatics company providing pioneering multi-omics solutions for biomedical research, today announced a strategic collaboration with Inotiv, Inc. (NASDAQ: NOTV) a leading Contract Research Organization (CRO). The collaboration is designed to accelerate AI-assisted drug discovery and enhance data-driven insights across the drug development continuum. For VUGENE it also represents an important entry into the pharmaceutical services market.

Wellcome Trust Research Assistant

About Us

Our guiding mission is to identify and investigate cellular and molecular mechanisms that cause and control inflammation and to relate these findings to human health and disease.

We are interdisciplinary in nature; by bringing together different disciplines, we will accelerate our understanding of the common as well as the unique mechanisms that contribute to inflammation-related pathologies.

Chemoinformatician (Principal Scientist / Associate Director)

OMass Therapeutics is a biotechnology company based in Oxford discovering medicines against highly- validated target ecosystems, such as membrane proteins or intracellular complexes. The company’s unique OdyssION™ technology platform comprises novel biochemistry techniques, next-generation native mass spectrometry, and custom chemistry. OMass is advancing a pipeline of small molecule therapeutics in rare diseases and immunological conditions, that target solute carriers, complex-bound proteins, and GPCRs.

Subscribe to